Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference

Rhea-AI Summary

Akebia Therapeutics announced that its CEO, John Butler, will present at the Jefferies Global Healthcare Conference on June 5, 2024, at 9:00 a.m. ET. The conference will be held in New York from June 4-6, 2024. The presentation will be accessible through a webcast on Akebia's investor website for 30 days post-event.

Positive

• CEO John Butler's participation in a major healthcare conference could enhance visibility for Akebia (AKBA).
• The webcast availability extends the reach of Akebia's presentation beyond the conference attendees.

Negative

• The press release does not mention any new product launches, clinical trial results, or financial updates, which could disappoint investors looking for substantive progress.
• The 30-day webcast access may restrict long-term investor engagement.

CAMBRIDGE, Mass., May 23, 2024 /PRNewswire/ -- Akebia Therapeutics^®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will present at the Jefferies Global Healthcare Conference on Wednesday, June 5 at 9:00 a.m. ET.

The Jefferies Global Healthcare Conference will take place in New York, NY on June 4-6, 2024.

A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.com for 30 days following the conference.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-the-jefferies-global-healthcare-conference-302153546.html

SOURCE Akebia Therapeutics, Inc.

FAQ

When will Akebia Therapeutics present at the Jefferies Global Healthcare Conference?

On June 5, 2024, at 9:00 a.m. ET.

Where is the Jefferies Global Healthcare Conference held?

In New York, NY, from June 4-6, 2024.

How can investors access Akebia's presentation?

Through a webcast on Akebia's investor website for 30 days following the conference.

What is Akebia Therapeutics' stock symbol?

AKBA.